EUVIMEDEUVIMED entdecken
Crossref

Development and Preliminary Evaluation of a 125 I-Labeled Radioligand ([ 125 I]iodotrazoline) for In Vitro Detection of Imidazoline-2 Binding Site in the Brain

Donglan Huang, Yiming Guo, Mengchao Cui iD, Hualong Fu iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Donglan Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Brain, Imidazoline Receptors, Imidazoles. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesBrainImidazoline ReceptorsImidazolesImidazolinesAnimalsRatsMiceMaleTissue DistributionAutoradiographyBinding SitesRats, Sprague-DawleyAstrocytesRadiopharmaceuticalsLigandsRadioligand Assay

Stichwörter der Autor:innen

125I-labeledautoradiographyex vivo biodistributionimidazoline-2 binding sitereactive astrocytes

Substanzen

Iodine RadioisotopesImidazoline Receptorsimidazoline receptor 2Iodine-125ImidazolesRadiopharmaceuticalsLigandsImidazolinesBU 224

Autor:innen und Institutionen

  • Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
  • State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health and State Key Laboratory of Molecular Vaccinolo…
  • Center for Advanced Materials Research & Faculty of Arts and Sciences, Beijing Normal University, Zhuhai 519087, P. R. China.

ORCID-Profile: Mengchao Cui, Hualong Fu

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Huang, D., Guo, Y., Cui, M., & Fu, H. (2025). Development and Preliminary Evaluation of a 125 I-Labeled Radioligand ([ 125 I]iodotrazoline) for In Vitro Detection of Imidazoline-2 Binding Site in the Brain. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01445

Vancouver

Huang D, Guo Y, Cui M, Fu H. Development and Preliminary Evaluation of a 125 I-Labeled Radioligand ([ 125 I]iodotrazoline) for In Vitro Detection of Imidazoline-2 Binding Site in the Brain. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01445

BibTeX
@article{Huang2025,
  author = {Huang, Donglan and Guo, Yiming and Cui, Mengchao and Fu, Hualong},
  title = {Development and Preliminary Evaluation of a 125 I-Labeled Radioligand ([ 125 I]iodotrazoline) for In Vitro Detection of Imidazoline-2 Binding Site in the Brain},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01445}
}
Kostenlos starten →